journal article·2024-06-04

Sulfated Chitosan-Modified CuS Nanocluster: A Versatile Nanoformulation for Simultaneous Antibacterial and Bone Regenerative Therapy in Periodontitis

Xiaoyu Chen, Ning Huang, Danyang Wang, Miao Zhang, Xuyang Deng, Fangze Guo, Bingcheng Yi, Changqing Yuan, Qihui Zhou

ACS Nano· Volume 18· Issue 22
Publisher page

Abstract

Periodontitis, a prevalent chronic inflammatory disease worldwide, is triggered by periodontopathogenic bacteria, resulting in the progressive destruction of periodontal tissue, particularly the alveolar bone. To effectively address periodontitis, this study proposed a nanoformulation known as CuS@MSN-SCS. This formulation involves coating citrate-grafted copper sulfide (CuS) nanoparticles with mesoporous silica (MSNs), followed by surface modification using amino groups and sulfated chitosan (SCS) through electrostatic interactions. The objective of this formulation is to achieve efficient bacteria removal by inducing ROS signaling pathways mediated by Cu 2+ ions. Additionally, it aims to promote alveolar bone regeneration through Cu 2+ -induced pro-angiogenesis and SCS-mediated bone regeneration. As anticipated, by regulating the surface charges, the negatively charged CuS nanoparticles capped with sodium citrate were successfully coated with MSNs, and the subsequent introduction of amine groups using (3-aminopropyl)triethoxysilane was followed by the incorporation of SCS through electrostatic interactions, resulting in the formation of CuS@MSN-SCS. The developed nanoformulation was verified to not only significantly exacerbate the oxidative stress of Fusobacterium nucleatum, thereby suppressing bacteria growth and biofilm formation in vitro, but also effectively alleviate the inflammatory response and promote alveolar bone regeneration without evident biotoxicity in an in vivo rat periodontitis model. These findings contribute to the therapeutic effect on periodontitis. Overall, this study successfully developed a nanoformulation for combating bacteria and facilitating alveolar bone regeneration, demonstrating the promising potential for clinical treatment of periodontitis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China

School of Stomatology, Qingdao University, Qingdao 266003, China

Institute of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China

Cancer Institute, Qingdao University, Qingdao 266071, China

Qingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266113, China

Funding

National Key Research and Development Program of China · Natural Science Foundation of Qingdao Municipality · Taishan Scholar Project of Shandong Province · National Natural Science Foundation of China · Leading Project of Science and Technology of Yantai Development Zone · Qingdao Demonstration and Guidance Project of Science and Technology to Benefit the People

References (69)

Show source-provided references
1. 10.1111/jcpe.1329010.1111/jcpe.13290 ↗
2. 10.1016/j.jdsr.2021.09.00510.1016/j.jdsr.2021.09.005 ↗
3. 10.1021/acsami.3c0453410.1021/acsami.3c04534 ↗
4. 10.31531/2581-4745.100013110.31531/2581-4745.1000131 ↗
5. 10.1186/s12951-023-02042-710.1186/s12951-023-02042-7 ↗
6. 10.1111/prd.1236810.1111/prd.12368 ↗
7. 10.1038/s41436-020-00985-y10.1038/s41436-020-00985-y ↗
8. 10.1038/s41368-019-0064-z10.1038/s41368-019-0064-z ↗
9. 10.1016/j.bioactmat.2020.11.01810.1016/j.bioactmat.2020.11.018 ↗
10. 10.1016/j.colsurfb.2019.11074810.1016/j.colsurfb.2019.110748 ↗
11. 10.1111/prd.1232510.1111/prd.12325 ↗
12. 10.1016/j.apsb.2022.10.02610.1016/j.apsb.2022.10.026 ↗
13. 10.1016/j.bioactmat.2022.10.02110.1016/j.bioactmat.2022.10.021 ↗
14. 10.1111/prd.1212110.1111/prd.12121 ↗
15. 10.1016/j.biomaterials.2021.12106910.1016/j.biomaterials.2021.121069 ↗
16. 10.1021/acsami.9b1733510.1021/acsami.9b17335 ↗
17. 10.1186/s12951-022-01501-x10.1186/s12951-022-01501-x ↗
18. 10.3390/pharmaceutics1504131210.3390/pharmaceutics15041312 ↗
19. 10.1016/j.drudis.2008.07.01010.1016/j.drudis.2008.07.010 ↗
20. 10.1039/C7RA05636B10.1039/C7RA05636B ↗
21. 10.1007/s12274-020-2824-710.1007/s12274-020-2824-7 ↗
22. 10.1016/j.bioactmat.2021.04.03310.1016/j.bioactmat.2021.04.033 ↗
23. 10.1016/j.cej.2020.12609610.1016/j.cej.2020.126096 ↗
24. 10.1021/acsami.8b2176610.1021/acsami.8b21766 ↗
25. 10.3389/fmolb.2020.58701210.3389/fmolb.2020.587012 ↗
26. 10.1039/C6NR09042G10.1039/C6NR09042G ↗
27. 10.3389/fchem.2021.64341110.3389/fchem.2021.643411 ↗
28. 10.1016/j.cej.2021.13020710.1016/j.cej.2021.130207 ↗
29. 10.1016/j.biomaterials.2008.12.01610.1016/j.biomaterials.2008.12.016 ↗
30. 10.1016/j.carbpol.2021.11788810.1016/j.carbpol.2021.117888 ↗
31. 10.1016/j.actbio.2018.02.03110.1016/j.actbio.2018.02.031 ↗
32. 10.1039/C4TB00919C10.1039/C4TB00919C ↗
33. 10.1039/C5DT00198F10.1039/C5DT00198F ↗
34. 10.1016/j.inoche.2021.10871810.1016/j.inoche.2021.108718 ↗
35. 10.1021/acsami.6b0537010.1021/acsami.6b05370 ↗
36. 10.1016/j.cis.2020.10216210.1016/j.cis.2020.102162 ↗
37. 10.1016/j.msec.2020.11152610.1016/j.msec.2020.111526 ↗
38. 10.1016/j.mset.2021.01.00110.1016/j.mset.2021.01.001 ↗
39. 10.1016/j.molliq.2018.11.07710.1016/j.molliq.2018.11.077 ↗
40. 10.1016/j.colsurfa.2023.13139710.1016/j.colsurfa.2023.131397 ↗
41. 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L ↗
42. 10.1039/C6RA28098F10.1039/C6RA28098F ↗
43. 10.1016/j.electacta.2010.03.07110.1016/j.electacta.2010.03.071 ↗
44. 10.1039/C8RA02153H10.1039/C8RA02153H ↗
45. 10.1016/j.matpr.2015.07.09810.1016/j.matpr.2015.07.098 ↗
46. 10.3390/nano705010210.3390/nano7050102 ↗
47. 10.1039/D0RA00566E10.1039/D0RA00566E ↗
48. 10.1186/s12951-022-01672-710.1186/s12951-022-01672-7 ↗
49. 10.1016/j.vaccine.2010.02.04710.1016/j.vaccine.2010.02.047 ↗
50. 10.1016/S0966-842X(02)00034-310.1016/S0966-842X(02)00034-3 ↗
51. 10.1038/s41579-018-0129-610.1038/s41579-018-0129-6 ↗
52. 10.3390/ma1222379810.3390/ma12223798 ↗
53. 10.1016/j.apsusc.2022.15426210.1016/j.apsusc.2022.154262 ↗
54. 10.1016/j.jcat.2013.01.02510.1016/j.jcat.2013.01.025 ↗
55. 10.1038/s41467-023-43571-x10.1038/s41467-023-43571-x ↗
56. 10.1002/adfm.20230071010.1002/adfm.202300710 ↗
57. 10.1021/acsami.2c0087710.1021/acsami.2c00877 ↗
58. 10.1016/j.cej.2023.14329210.1016/j.cej.2023.143292 ↗
59. 10.1155/2015/61548610.1155/2015/615486 ↗
60. 10.1016/j.cis.2022.10274610.1016/j.cis.2022.102746 ↗
61. 10.1007/BF0037276210.1007/BF00372762 ↗
62. 10.1002/adfm.20220001110.1002/adfm.202200011 ↗
63. 10.15212/CVIA.2022.001810.15212/CVIA.2022.0018 ↗
64. 10.1002/adfm.20210561410.1002/adfm.202105614 ↗
65. 10.1016/j.compositesb.2022.11008510.1016/j.compositesb.2022.110085 ↗
66. 10.1111/prd.1249210.1111/prd.12492 ↗
67. 10.1002/adma.20200243910.1002/adma.202002439 ↗
68. 10.1002/adma.20210705410.1002/adma.202107054 ↗
69. 10.1021/jacs.2c0960810.1021/jacs.2c09608 ↗